Trulance

Quote








Glad your killing it for now. I am worried. Efficacy data is sound and clinical data demonstrates drug has a much better safety profile than Amitiza or Linzess.

Also, AMitiza falling off most commercial plans in my area. Boss wants me to go after OIC. This is a mess.
 












Your missing it pal. Linzess has same black box warning and gobbled up our market share. Both are GCC agonist.

This drug is much better than ours and Linzess. Glad your numbers were up for Jan/Feb. They are about to get pounded in Q2. Amitiza is the low hanging fruit.

Trulance PI is out. They have 1 side effect in their labeling just one. Time to jump! I am interviewing with Salix this week!
 




Here is what you are not understanding. Linzess has same black box warning Sherlock. Both are GCC agonist expect Trulance diarrhea rate is much lower and that is their only side effect, nothing else.

Check out Trulance PI out online. We are in trouble. My numbers for Amitiza were good as well for Jan/Feb, but Q3 Amitiza is the low hanging fruit. Time to jump! I have a Salix interview next week.
 




Trulance is being launched by 150 rent a reps from Publicis, that's all. They will barely make a dent in this market. We will continue to be the punching bag for Allergan.
 








Most of those supposed "Rent A Reps" were taken from Allergan. No sale of the company yet, but keep saying until you are right (some day).

Drug is clean. GI's need another agent in a much needed disease state. We are in trouble.
 








According to the data from takeda our territory has zero truliance. Also it has only CIC indication. I doubt that product does anything. What is is 3rd to market if you don't count movantiq. I'd be worried about taking share from linzess instead of truliance.
And takeda messed that up. First to market and fell asleep at the wheel, letting linzess take the market majority smh.
 




anonymous said:
So far the last 5 weeks Trulance is out selling Linzess. The doctors are going to hear good things from the Px and spread the good news around. Bonus time!
Click to expand...
Trulance isn't a factor. I really believe that the nesina family was a better product than the other DPP-4 inhibitors but it was 4th to market. The insurance companies already made there decisions on which products they are going to cover. But if you are a rep for trulance, getting 10 scripts in a month might be a huge bonus at launch. For legit significance in the market their managed markets reps are going to have to get coverage. That won't be easy in a set market.
 




anonymous said:
Trulance isn't a factor. I really believe that the nesina family was a better product than the other DPP-4 inhibitors but it was 4th to market. The insurance companies already made there decisions on which products they are going to cover. But if you are a rep for trulance, getting 10 scripts in a month might be a huge bonus at launch. For legit significance in the market their managed markets reps are going to have to get coverage. That won't be easy in a set market.
Click to expand...
Also linzess reps basically pay off the GIs and big docs. At one point big GIs were getting multiple speaker events per month. Maybe trulance can pay more for speaker events and get a bigger piece of the pie....
 




anonymous said:
According to the data from takeda our territory has zero truliance. Also it has only CIC indication. I doubt that product does anything. What is is 3rd to market if you don't count movantiq. I'd be worried about taking share from linzess instead of truliance.
And takeda messed that up. First to market and fell asleep at the wheel, letting linzess take the market majority smh.
Click to expand...

I would check again next week. Are you in a major metropolitan area. Free 7 days packs are out here, like Holloween candy. Is anyone worried?
 




anonymous said:
I would check again next week. Are you in a major metropolitan area. Free 7 days packs are out here, like Holloween candy. Is anyone worried?
Click to expand...
No so much. When Linzess was launched, remember they gave 30 day stock bottles for the first 6 months. 7 days isn't enough to see if Trulance is effective, plus all reports I'm getting in the field is diarrhea rates are very similar to Linzess. Most Trulance patients will give up after their 7 day blister pack and feel it wasn't worth it, especially if they were told by their Dr they weren't supposed to get diarrhea and they did. Synergy changed the definition of diarrhea in their trials from how Amitiza and Linzess were measured. Amitiza will still be preferred CIC drug for patients who don't want diarrhea.
 








Top Bottom
Back
Quote